Patients on GLP-1 medications lost about half as much weight as participants did in clinical trials, NYU researchers found.

Researchers found after bariatric procedures, patients lost an average of 58 pounds after two years, compared to 12 pounds ...

Type 2 diabetes patients taking semaglutide, often sold as Ozempic or Wegovy, have a slightly lower risk of stroke compared ...

They were designed to treat diabetes, then prescribed for weight loss, and now—as researchers are finding—they might hold the ...

While some compounding pharmacies have stopped making alternatives to Wegovy and Zepbound since shortages were declared over, ...

An investigational drug developed by Eolo Pharma is showing promise in animal experiments and an early human trial. It could ...

Two companion papers out of Rutgers University — published June 14 in Nature Metabolism and Nature Communications—have traced ...

WEIGHT loss jabs have taken the UK by storm – but for those looking for a more natural alternative, there’s a food everyone’s talking about. It’s been dubbed ‘the ...

Semaglutide medications like Ozempic and Wegovy have shown proven results for managing conditions like type 2 diabetes and obesity. Also known as GLP-1 agonists, these drugs work by mimicking a ...

SO-CALLED “miracle” weight-loss jabs are far less effective in the real world than in clinical trials, a major study has revealed. The new findings could have big implications for Brits ...

AS electrical pulses surge into my bottom, I peer over my shoulder and see my cheeks going like the clappers. But just as I thought the sight of my sagging glutes bouncing up and down like a pair ...

Denmark-based multinational pharmaceutical company Novo Nordisk will be making available in the Philippines within this year ...